|
丙泊酚的非麻醉作用的研究进展
|
Abstract:
[1] | J. A. Gonzalez-Correa, et al. Effects of propofol on the leukocyte nitric oxide pathway: In vitro and ex vivo studies in surgical patients. Naunyn-Schmiedeberg’s Archives of Pharmacology, 2008, 376(5): 331-339. |
[2] | H. K. Song, D. C. Jeong. The effect of propofol on cytotoxicity and apoptosis of lipopolysaccharide-treated mononuclear cells and lymphocytes. Anesthesia & Analgesia, 2004, 98(6): 1724- 1728. |
[3] | Y. C. Liu, et al. Differential protection against oxidative stress and nitric oxide overproduction in cardiovascular and pulmonary systems by propofol during endotoxemia. Journal of Biomedical Science, 2009, 16: 8. |
[4] | X. P. Dong, T. L. Xu. The actions of propofol on gamma-ami- nobutyric acid-A and glycine receptors in acutely dissociated spinal dorsal horn neurons of the rat. Anesthesia & Analgesia, 2002, 95(4): 907-914. |
[5] | O. H. Wilder-Smith, M. Kolletzki and C. H. Wilder-Smith. Sedation with intravenous infusions of propofol or thiopentone. Effects on pain perception. Anaesthesia, 1995, 50(3): 218-222. |
[6] | Y. C. Tsai, et al. Propofol does not reduce infarct volume in rats undergoing permanent middle cerebral artery occlusion. Acta anaesthesiologica Sinica, 1994, 32(2): 99-104. |
[7] | C. Liang, et al. Propofol attenuates cerebral ischemia/reperfu- sion injury partially using heme oxygenase-1. Journal of Neurosurgical Anesthesiology, 2013, 25(3): 311-316. |
[8] | J. He, et al. Propofol exerts hippocampal neuron protective effects via up-regulation of metallothionein-3. Neurological Sciences, 2013, 34(2): 165-171. |
[9] | L. J. Velly, et al. Neuroprotective effects of propofol in a model of ischemic cortical cell cultures: Role of glutamate and its transporters. Anesthesiology, 2003, 99(2): 368-375. |
[10] | C. Adembri, et al. Neuroprotective effects of propofol in models of cerebral ischemia: Inhibition of mitochondrial swelling as a possible mechanism. Anesthesiology, 2006, 104(1): 80-89. |
[11] | 李岩, 陈国忠, 刘韧等. 异丙酚减轻大鼠创伤性脑水肿及相关机制的研究. 医学综述, 2009, 15(9): 1410-1412. |
[12] | M. Coburn, et al. Incidence of postoperative nausea and emetic episodes after xenon anaesthesia compared with propofol-based anaesthesia. British Journal of Anaesthesia, 2008, 100(6): 787- 791. |
[13] | A. Borgeat, H. R. Stirnemann. Antiemetic effect of propofol. Anaesthesist, 1998, 47(11): 918-924. |
[14] | A. Borgeat, et al., Propofol and spontaneous movements: An EEG study. Anesthesiology, 1991, 74(1): 24-27. |
[15] | B. L. Appadu, P. G. Strange and D.G. Lambert. Does propofol interact with D2 dopamine receptors? Anesthesia & Analgesia, 1994, 79(6): 1191-1192. |
[16] | S. A. Helmy, R. J. Al-Attiyah. The im-munomodulatory effects of prolonged intravenous infusion of propofol versus midazolam in critically ill surgical patients. Anaesthesia, 2001, 56(1): 4-8. |
[17] | A. Kushida, T. Inada and K. Shingu. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacology and Immunotoxicology, 2007, 29(3-4): 477-486. |
[18] | V. Volke, et al. Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze. Neuroreport, 1995, 6(10): 1413-1416. |
[19] | A. D. Manataki, et al. Lipid peroxidation and the use of emulsified propofol in laparoscopic surgery. Surgical Endoscopy, 2001. 15(9): 950-953. |
[20] | P. Sanchez-Conde, et al. The comparative abilities of propofol and sevoflurane to modulate inflammation and oxidative stress in the kidney after aortic cross-clamping. Anesthesia & Analge- sia, 2008, 106(2): 371-378. |